scispace - formally typeset
Open AccessJournal Article

Genetics of susceptibility to pristane-induced plasmacytomas in BALB/cAn: reduced susceptibility in BALB/cJ with a brief description of pristane-induced arthritis.

M Potter, +1 more
- 01 Oct 1981 - 
- Vol. 127, Iss: 4, pp 1591-1595
Reads0
Chats0
TLDR
Pristane-treated inbred strains of mice first injected with pristane as neonates developed a reduced number of plasmacytomas as compared with BALB/cAn, and arthritis first appeared in the ankle joints after a latent period of 4 mo or more.
Abstract
BALB/cAn and BALB/cJ inbred strains of mice were separated 43 yr ago, but are still very closely related because they carry the same allelomorphs at many loci. When injected 3 times i.p. with 0.5 ml of pristane (2, 6, 10, 14 tetramethylpentadecane) 11% of strain BALB/cJ develop plasmacytomas in contrast to 61% in BALB/cAn sublines. BALB/cJ first injected with pristane as neonates also developed a reduced number of plasmacytomas as compared with BALB/cAn. About 20% of pristane-treated BALB/cAn and 70% of pristane-treated BALB/cJ develop arthritis, which first appeared in the ankle joints after a latent period of 4 mo or more.

read more

Citations
More filters
Book ChapterDOI

Interleukin-6 in biology and medicine

TL;DR: Application of IL-6 is promising in cancer treatment as well as in treatment of radiation- or chemotherapy-induced myelosuppression and the cell biology of the intracellular events that link transduction to gene regulation is an important area, and work on these topics helps to understand such phenomena as multifunction of IL -6 and bidirectional effects of cell growth depending on the cell type.
Journal ArticleDOI

IL-6 in autoimmune disease and chronic inflammatory proliferative disease.

TL;DR: Evidence for the involvement of IL-6 in the pathophysiology of autoimmune diseases and chronic inflammatory proliferative diseases (CIPD) is reviewed and the possible molecular mechanisms of its involvement are discussed.
Journal ArticleDOI

Interleukin 6 and its receptor: ten years later.

TL;DR: JAK tyrosine kinase is a key molecule that can initiate multiple signal-transduction pathways by inducing the tyrosinesine-phosphorylation of the cytokine receptor, gp130 in the case of IL-6, on which several signaling molecules are recruited, including STAT, a signal transducer and activator of transcription, and SHP-2, which links to the Ras-MAP kinase pathway.
Journal ArticleDOI

Murine Models of Systemic Lupus Erythematosus

TL;DR: In this article, the effect specific targeted therapies have on immune homeostasis and knowledge gained from mouse models will provide novel therapy targets for the treatment of systemic lupus erythematosus (SLE).
Journal ArticleDOI

A role for fungal β-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice

TL;DR: Specific microbes, including fungi and viruses, may evoke autoimmune arthritis such as rheumatoid arthritis by stimulating innate immunity in individuals who harbor potentially arthritogenic autoimmune T cells as a result of genetic anomalies or variations.
Related Papers (5)